美洛昔康对慢性前列腺炎患者前列腺液中SIgA水平的影响  

Study on meloxicam intervention of SIgA level in prostatic fluid of patients with chronic prostatitis

作　　者：周海永 邵四海[2] 

机构地区：[1]杭州市萧山医院泌尿外科,浙江杭州311200 [2]浙江省湖州市第一人民医院泌尿外科,浙江湖州313000

出　　处：《中国现代医生》2013年第12期79-80,83,共3页China Modern Doctor

基　　金：浙江省医药卫生科技计划项目(2012KYB199)

摘　　要：目的研究美洛昔康对慢性前列腺炎患者前列腺液中SIgA水平的影响。方法 80例慢性前列腺炎患者依治疗方法不同分为观察组和对照组:对照组服用盐酸左氧氟沙星片和盐酸坦索罗辛缓释胶囊,观察组在对照组用药方式的基础上加用美洛昔康片。结果治疗8周后,观察组患者的总有效率82.50%高于对照组总有效率60.00%,差异有统计学意义(P<0.05);治疗8周后,观察组患者的前列腺液白细胞数低于对照组患者的前列腺液白细胞数,差异有统计学意义(P<0.05);治疗8周后,观察组慢性前列腺炎患者的前列腺液中SIgA水平较对照组患者下降明显,差异有高度统计学意义(P<0.01)。结论美洛昔康用于治疗慢性前列腺炎疗效可靠,并可明显改善患者前列腺液中的SIgA水平。Objective To study of meloxicam intervention of SIgA level prostatic fluid in patients with chronic pro- statitis. Methods A total of 80 eases of chronic prostatitis patients according to the different treatment were divided into the observation group and the control group. Control group：Taking levofloxacin hydrochloride tablets and tamsulosin hydroehloride sustained release capsules in the treatment of patients with chronic prostatitis. Observation group：with medication of the control group as the foundation,combined with meloxicam tablet in the treatment of patients with chronic prostatitis. Results After 8 weeks of treatment, the total efficiency of the observation group were 82.50% high- er than 60% in the control group,there were significant differences （P 〈 0.05）. After 8 weeks of treatment, WBC count of the observation group were lower than that of the control group, there were significant differences（P 〈 0.05）. After 8 weeks of treatment,the levels of SIgA in prostatic fluid of patients with chronic prostatitis of the observation group less than patients in the control group,there were significant differences （P 〈 0.01）. Conclusion The curative ef- fect is reliable about meloxicam for treatment of patients with chronic prostatitis, and can obviously improve the level of SIgA in prostatic fluid.

关 键 词：美洛昔康片 慢性前列腺炎 前列腺液 白细胞数 分泌型免疫球蛋白A 

分 类 号：R697.33[医药卫生—泌尿科学]